Mint Explainer: Why do Indian drug makers challenge global giants' patents?
Indian drugmakers primarily produce generics, or copycat versions, and in order to enter the market, they either have to wait for patents to expire or challenge the innovator’s rights.
Indian drugmakers primarily produce generics, or copycat versions, and in order to enter the market, they either have to wait for patents to expire or challenge the innovator’s rights.
What's Your Reaction?
Economist Admin
Admin managing news updates, RSS feed curation, and PR content publishing. Focused on timely, accurate, and impactful information delivery.
